Drug Shortage Report for DEMYLOCAN
| Report ID | 140576 |
| Drug Identification Number | 02484811 |
| Brand name | DEMYLOCAN |
| Common or Proper name | Decitabine |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER |
| Route of administration | INTRAVENOUS |
| Packaging size | 20mL |
| ATC code | L01BC |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-04-28 |
| Actual start date | 2021-04-28 |
| Estimated end date | 2021-06-21 |
| Actual end date | 2021-06-21 |
| Shortage status | Resolved |
| Updated date | 2021-06-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-06-22 | English | Compare |
| v8 | 2021-06-21 | French | Compare |
| v7 | 2021-06-21 | English | Compare |
| v6 | 2021-06-17 | French | Compare |
| v5 | 2021-06-17 | English | Compare |
| v4 | 2021-06-15 | French | Compare |
| v3 | 2021-06-15 | English | Compare |
| v2 | 2021-06-08 | French | Compare |
| v1 | 2021-06-08 | English | Compare |
Showing 1 to 9 of 9